NYMC Faculty Publications
In CV Disease, Clopidogrel Reduces Nonfatal MI and MACE vs. Aspirin but Not Stroke or Mortality
Author Type(s)
Faculty, Resident/Fellow
DOI
10.7326/J22-0094
Journal Title
Annals of Internal Medicine
First Page
JC137
Document Type
Article
Publication Date
12-1-2022
Department
Medicine
Abstract
Tasoudis PT, Kyriakoulis IG, Sagris D, et al. Thromb Haemost. 2022;122:1879-87. 35577054.
Recommended Citation
Goel, A., & Malik, A. H. (2022). In CV Disease, Clopidogrel Reduces Nonfatal MI and MACE vs. Aspirin but Not Stroke or Mortality. Annals of Internal Medicine, 175 (12), JC137. https://doi.org/10.7326/J22-0094
COinS